For many years bisphosphonates and anti-resorptive agents have been the main stay of osteoporosis treatment. Though effective at preventing fractures, they are not able to improve bone density. Anabolic agents including Teriparatide and Romosozumab are enabling us to proactively improve bone density. Will using anabolic agents followed by anti-resorptives be the new way we treat osteoporosis?

Learning outcomes:

• What is osteoporosis
• How is it traditionally managed
• Place in therapy of teriparatide and Romosozumab in osteoporosis